<DOC> 
<DOCNO>1100630_business_story_12626841.utf8</DOCNO> 
<TEXT> 
         
The Telegraph - Calcutta (Kolkata) | Business | Drug duo seek delisting 
                                                                                                                           6                                                                                      Drug duo seek delisting 
          OUR SPECIAL CORRESPONDENT                               
	Mumbai, June 29: Two multinationals today started the process of delisting their Indian subsidiaries from the stock markets, following in the footsteps of the Linde group. While AstraZeneca Pharmaceuticals AB proposes to make a voluntary delisting offer, Sulzer AG is planning to buy around 20 per cent shares and later delist its subsidiary.         
	In a communication to the bourses today, AstraZeneca Pharma India said it had received a letter from its promoter seeking to make a delisting offer to its shareholders.         
	The parent currently holds 89.99 per cent of the Indian arm. The companys board of directors today cleared the voluntary delisting offer from the Sweden-based promoter. News of the offer fuelled shares of AstraZeneca Pharma that were locked in at the upper 20 per cent circuit limit. Its shares rose Rs 201.15 to finish at Rs 1,207.05 on the Bombay Stock Exchange.         
	Sulzer AG is planning to acquire up to 6,88,908 shares, representing 19.97 per cent of the equity of Sulzer India. In an announcement to its shareholders, Sulzer India said the objective of the promoter in making the delisting offer is to obtain full ownership of the company and integrate it into the multinationals global operations.                                                                                                                                                               
</TEXT> 
</DOC>